4|0|Public
50|$|<b>Emylcamate</b> {{also has}} a faster intra-parenteral onset then meprobabamate, 3 minutes {{compared}} with 35.|$|E
5000|$|... 3-Methyl-3-pentanol (IUPAC name: 3-methylpentan-3-ol) is {{an organic}} {{chemical}} compound and a tertiary hexanol. It {{is used in}} the synthesis of the tranquilizer <b>emylcamate.</b>|$|E
5000|$|A {{study of}} the drug's effects in mice was done in 1959. It {{concluded}} that at 50 mg/kg <b>emylcamate</b> gave a 63% decrease in motor activity compared with meprobamate's 32% decrease, a doubling in effective potency. The therapeutic index in mice was also established: ...|$|E
50|$|<b>Emylcamate</b> (marketed as Striatran by Merck) is an {{anxiolytic}} {{and muscle}} relaxant. It was patented in the US in 1961 (US Patent 2,972,564) and advertised {{for the treatment}} of anxiety and tension. It was claimed to be superior to meprobamate, which was the market leader at the time. It is no longer prescribed.|$|E

